There was a nonsignificant trend toward higher calculated LVAD flow in the macitentan group.
← all excerpts
SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation.
1
—
—
There was a nonsignificant trend toward higher calculated LVAD flow in the macitentan group.